Literature DB >> 19194682

[Role of tyrosine kinases in tumor progression of the head and neck].

C Bergmann1, E Wimmer.   

Abstract

Receptor tyrosine kinases play a key role in intercellular communication to maintain cellular integrity in tissues. Genetic alterations in these receptor-enzyme complexes or in their downstream signalling pathways may alter cellular characteristics such as proliferation, adhesion, differentiation and apoptosis. This result explains the role of these receptor complexes in the pathogenesis of malignancies. This article resumes the molecular basis and grouping of this receptor family and discusses the role of receptor alterations in carcinogenesis. This will be exemplified using the fibroblast growth factor receptor (FGFR) subfamily as well as the significance of single nucleotide polymorphism in cancer progression. The authors show that the application of molecular therapy is very promising and should be taken into consideration in concepts of multimodal cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194682     DOI: 10.1007/s00106-008-1868-x

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  92 in total

1.  Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues.

Authors:  S E Hughes
Journal:  J Histochem Cytochem       Date:  1997-07       Impact factor: 2.479

Review 2.  p16(MTS-1/CDKN2/INK4a) in cancer progression.

Authors:  J W Rocco; D Sidransky
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

Review 3.  Oncoprotein signalling and mitosis.

Authors:  A D Laird; D Shalloway
Journal:  Cell Signal       Date:  1997 May-Jun       Impact factor: 4.315

4.  Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.

Authors:  Andrea Cavalot; Tiziana Martone; Nicolò Roggero; Gabriele Brondino; Marco Pagano; Giorgio Cortesina
Journal:  Head Neck       Date:  2007-07       Impact factor: 3.147

5.  A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos.

Authors:  T Iwata; L Chen; C Li; D A Ovchinnikov; R R Behringer; C A Francomano; C X Deng
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

6.  Fibroblast growth factor downregulates expression of a basic helix-loop-helix-type transcription factor, scleraxis, in a chondrocyte-like cell line, TC6.

Authors:  T Kawa-uchi; A Nifuji; N Mataga; E N Olson; J Bonaventure; K Shinomiya; Y Liu; M Noda
Journal:  J Cell Biochem       Date:  1998-09-15       Impact factor: 4.429

7.  Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.

Authors:  Sylvia Streit; Johannes Bange; Alexander Fichtner; Stephan Ihrler; Wolfgang Issing; Axel Ullrich
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

8.  BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.

Authors:  J Adnane; P Gaudray; C A Dionne; G Crumley; M Jaye; J Schlessinger; P Jeanteur; D Birnbaum; C Theillet
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

9.  Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.

Authors:  Yuki Morimoto; Toshifumi Ozaki; Mamoru Ouchida; Norifumi Umehara; Norihide Ohata; Aki Yoshida; Kenji Shimizu; Hajime Inoue
Journal:  Cancer       Date:  2003-11-15       Impact factor: 6.860

10.  FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern.

Authors:  J Partanen; T P Mäkelä; E Eerola; J Korhonen; H Hirvonen; L Claesson-Welsh; K Alitalo
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.